Skip to main content


PubMed and PubMed CentralWe are delighted to announce that Cancers of the Head & Neck is now indexed with PubMed and PubMed Central, and as such all articles published in the journal are now visible and searchable in these databases.

We would like to thank everyone for supporting the journal and contributing to this success.

Featured Review: Adaptive radiotherapy for head and neck cancer

Adaptive radiotherapy for head and neck cancer imageAnatomy-adapted ART is a promising modality to improve rates of xerostomia and coverage in individuals who experience significant volumetric changes during radiation, while R-ART is currently being studied to assess its utility in either dose escalation of radioresistant disease, or de-intensification of surrounding normal tissue following treatment response. In this article, Howard E. Morgan & David J. Sher review the existing literature and recent advances regarding A-ART and R-ART.

Impact of COVID-19 on journal operations

COVID-19As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

We are trying our best to work through this crisis as efficiently and effectively as possible and thank you for your support and patience during these challenging times.

Thumbnail image by Felipe Esquivel Reed, used under Creative Commons Attribution-Share Alike 4.0 license.

What is trending?

AltmetricClick here to see which articles published in Cancers of the Head & Neck have been shared the most in the past three months.



Dr Barbara Burtness, Yale University School of Medicine, USA

Please click here to read the Editor's Profile.

Aims and scope

Cancers of the Head & Neck is an open access, peer-reviewed journal dedicated to publishing articles on pre-clinical and translational research, as well as research related to the clinical management of head and neck cancers. This includes cancers of the oral cavity, pharynx, larynx, paranasal sinuses, nasal cavity and salivary glands. Articles related to the etiology, pathophysiology, prevention, diagnosis, treatment and survivorship of these cancers are all considered.


Annual Journal Metrics

  • Speed
    53 days to first decision for reviewed manuscripts only
    48 days to first decision for all manuscripts
    182 days from submission to acceptance
    23 days from acceptance to publication

    8 Altmetric Mentions